Published in Gene Ther on March 01, 2005
Phosphorothioate-stimulated uptake of short interfering RNA by human cells. EMBO Rep (2005) 0.93
A mechanism of gene amplification driven by small DNA fragments. PLoS Genet (2012) 0.81
A hexanucleotide selected for increased cellular uptake in cis contains a highly active CpG-motif in human B cells and primary peripheral blood mononuclear cells. Immunology (2006) 0.77
DNA-fragments are transcytosed across CaCo-2 cells by adsorptive endocytosis and vesicular mediated transport. PLoS One (2013) 0.75
Expression of p21 proteins in Escherichia coli and stereochemistry of the nucleotide-binding site. EMBO J (1986) 2.85
Negative feedback regulation of wild-type p53 biosynthesis. EMBO J (1995) 2.52
Theoretical design of antisense RNA structures substantially improves annealing kinetics and efficacy in human cells. Nat Biotechnol (1998) 1.80
A theoretical approach to select effective antisense oligodeoxyribonucleotides at high statistical probability. Nucleic Acids Res (1999) 1.73
Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids. J Virol (1998) 1.70
Co-expression of the subunits of the heterodimer of HIV-1 reverse transcriptase in Escherichia coli. J Biol Chem (1989) 1.68
RNA accessibility prediction: a theoretical approach is consistent with experimental studies in cell extracts. Nucleic Acids Res (2000) 1.27
In vitro selection of fast-hybridizing and effective antisense RNAs directed against the human immunodeficiency virus type 1. Nucleic Acids Res (1993) 1.24
Adeno-associated virus type 2-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) replication: involvement of p78rep/p68rep and the HIV-1 long terminal repeat. J Gen Virol (1992) 1.22
Concepts to automate the theoretical design of effective antisense oligonucleotides. Bioinformatics (2001) 1.17
Characterization of cDNA coding for the complete light meromyosin portion of a rabbit fast skeletal muscle myosin heavy chain. Eur J Biochem (1987) 1.16
Identification and analysis of antisense RNA target regions of the human immunodeficiency virus type 1. Nucleic Acids Res (1991) 1.14
Complementary large loops determine the rate of RNA duplex formation in vitro in the case of an effective antisense RNA directed against the human immunodeficiency virus type 1. J Mol Biol (1993) 1.09
Incorporation of the catalytic domain of a hammerhead ribozyme into antisense RNA enhances its inhibitory effect on the replication of human immunodeficiency virus type 1. Nucleic Acids Res (1993) 1.08
Adeno-associated virus type 2 rep gene-mediated inhibition of basal gene expression of human immunodeficiency virus type 1 involves its negative regulatory functions. J Virol (1994) 1.05
Inhibition of constitutive serine phosphatase activity in T lymphoma cells results in phosphorylation of pp19/cofilin and induces apoptosis. J Immunol (1996) 1.01
Electrotransfection of human lymphoid and myeloid cell lines. Nucleic Acids Res (1988) 1.01
Dissociation of long-chain duplex RNA can occur via strand displacement in vitro: biological implications. Nucleic Acids Res (1996) 1.00
A three-nucleotide helix I is sufficient for full activity of a hammerhead ribozyme: advantages of an asymmetric design. Nucleic Acids Res (1994) 0.97
Mechanistic insights into p53-promoted RNA-RNA annealing. J Mol Biol (1997) 0.94
The subcellular localization and length of hammerhead ribozymes determine efficacy in human cells. Nucleic Acids Res (1997) 0.93
Length dependence of RNA-RNA annealing. J Mol Biol (1999) 0.91
Theoretical design of antisense genes with statistically increased efficacy. Nucleic Acids Res (2000) 0.91
Implications of RNA structure on the annealing of a potent antisense RNA directed against the human immunodeficiency virus type 1. Biochemistry (1997) 0.90
Extension of helix II of an HIV-1-directed hammerhead ribozyme with long antisense flanks does not alter kinetic parameters in vitro but causes loss of the inhibitory potential in living cells. Nucleic Acids Res (1994) 0.90
In vitro and in vivo action of antisense RNA. Mol Biotechnol (1996) 0.89
The association of complementary ribonucleic acids can be strongly increased without lowering Arrhenius activation energies or significantly altering structures. Biochemistry (1997) 0.89
A spermidine-induced conformational change of long-armed hammerhead ribozymes: ionic requirements for fast cleavage kinetics. Nucleic Acids Res (1997) 0.88
In vitro selection supports the view of a kinetic control of antisense RNA-mediated inhibition of gene expression in mammalian cells. Nucleic Acids Res (2000) 0.87
Phosphorothioate-stimulated cellular uptake of siRNA: a cell culture model for mechanistic studies. Curr Pharm Des (2008) 0.84
Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes. J Mol Biol (1996) 0.83
Kinetic selection of HPV 16 E6/E7-directed antisense nucleic acids: anti-proliferative effects on HPV 16-transformed cells. Nucleic Acids Res (1999) 0.83
Reduction in replication of the human immunodeficiency virus type 1 in human T cell lines by polymerase III-driven transcription of chimeric tRNA-antisense RNA genes. Antisense Res Dev (1994) 0.83
Oligodeoxyribonucleotide uptake in primary human hematopoietic cells is enhanced by cationic lipids and depends on the hematopoietic cell subset. Blood (1998) 0.80
The hepatitis B virus posttranscriptional regulatory element contains a highly stable RNA secondary structure. Biochem Biophys Res Commun (1997) 0.80
Structure-function relationships of HIV-1 reverse transcriptase determined using monoclonal antibodies. J Biol Chem (1992) 0.80
Recombinant AAV-2 harboring gfp-antisense/ribozyme fusion sequences monitor transduction, gene expression, and show anti-HIV-1 efficacy. Gene Ther (1999) 0.79
Theoretical and experimental selection parameters for HBV-directed antisense RNA are related to increased RNA-RNA annealing. Biol Chem (1997) 0.79
31P-NMR spectra of the Ha-ras p21.nucleotide complexes. Biochem Biophys Res Commun (1986) 0.78
[Breast cancer diagnostics based on extracellular DNA and RNA circulating in blood]. Biomed Khim (2008) 0.78
Ki-67-directed antisense therapy in an orthotopic renal cell carcinoma model. Eur Urol (2004) 0.78
Multiple site-specific cleavage of HIV RNA by transcribed ribozymes from shotgun-type trimming plasmid. Nucleic Acids Symp Ser (1993) 0.77
Hammerhead ribozyme activity in the presence of low molecular weight cellular extract. Antisense Nucleic Acid Drug Dev (1997) 0.76
Expression of native rabbit light meromyosin in Escherichia coli. Observation of a powerful internal translation initiation site. J Mol Biol (1989) 0.76
Design and production of asymmetric hammerhead ribozymes. Methods Mol Biol (1997) 0.76
An efficient expression vector (pPLEX) for bacterial synthesis of non-fusion proteins and protein domains. Nucleic Acids Res (1987) 0.75
High speed chemical DNA sequence determination. Nucleic Acids Res (1986) 0.75
Facilitators of RNA-RNA annealing: implications for the catalytic cycle of hammerhead ribozymes. Biochem Soc Trans (1996) 0.75
Purification and characterization of an active form of the p78Rep protein of adeno-associated virus type 2 expressed in Escherichia coli. Protein Expr Purif (1997) 0.75
[Ki-67 antisense therapy in murine renal cell carcinoma models]. Aktuelle Urol (2005) 0.75
Disinfection of cell-associated and extracellular HIV-1 by PUVA treatment. J Virol Methods (1997) 0.75
Replication of the human immunodeficiency virus type 1 is inhibited by the adeno-associated virus rep gene. Biochem Soc Trans (1991) 0.75
Selection of fast-hybridizing complementary RNA species in vitro. Methods Mol Biol (1997) 0.75